9:46am ET
Investing
5 Stocks Under $10 With Huge Dividends and King-Size Upside Potential
Here are five stocks trading around the $5 to $10 level that offer investors ultra-high-yield dividends and king-size upside potential.
Companies
/Financial Services
BlackRock Technology and Private Equity Term Trust
$8.68
▼ $0.04 (−0.43%) today
Markets closed · 10:59pm ET
BTX at a Glance
Valuation
- Market cap
- $1.0B
- P/E ratio
- 2.6
Profitability
- EPS (TTM)
- $3.40
Price
- 52-week range
- $6 – $9
- Street target
- $3.00
Headquartered in New York, NY Fiscal year ends December NYSE: BTX brooklynitx.com
About BlackRock Technology & Private Equity Term Trust
Brooklyn ImmunoTherapeutics, Inc. (BTX) is a clinical-stage biopharmaceutical company focused on advancing innovative therapies for cancer treatment, leveraging its proprietary technology platforms. Headquartered in Brooklyn, New York, the company is committed to addressing unmet medical needs in oncology through the development of both cellular and genetic therapies. With a strong emphasis on research and development, Brooklyn ImmunoTherapeutics aims to improve patient outcomes and enhance the quality of life for cancer patients internationally.
Frequently Asked Questions
What does BlackRock Technology & Private Equity Term Trust do?
Brooklyn ImmunoTherapeutics, Inc. (BTX) is a clinical-stage biopharmaceutical company focused on advancing innovative therapies for cancer treatment, leveraging its proprietary technology platforms.
What is the BTX stock price target?
The Wall Street consensus 12-month price target for BTX is $3.00.